Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF

被引:54
作者
LopezIlasaca, M
Li, WQ
Uren, A
Yu, JC
Kazlauskas, A
Gutkind, JS
Heidaran, MA
机构
[1] ORQUEST BIOTECHNOL,MT VIEW,CA 94043
[2] UNIV JENA,FAC MED,MAX PLANCK RES GRP,D-07747 JENA,GERMANY
[3] NATL INST CANC RES,NIH,BETHESDA,MD 20892
[4] COR THERAPEUT,S SAN FRANCISCO,CA 94080
[5] HARVARD UNIV,SCH MED,DIV SIGNAL TRANSDUCT,BOSTON,MA
[6] NIDR,BETHESDA,MD 20892
关键词
D O I
10.1006/bbrc.1997.6289
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular mechanism by which cell surface receptors stimulate the serine/threonine kinase activity of c-Jun N-terminal kinases (JNKs) was investigated using a transient cotransfection experiments in COS-7 cells, Our data demonstrate that JNK activity is potently induced by platelet derived growth factor (PDGF) upon expression of beta PDGFR wild type (beta RWT). However, PDGF failed to mediate JNK activation in cells expressing beta PDGFR mutant lacking the binding site for phosphatidylinositol-3 (PI-3) kinase but not for phospholipase C gamma (PLC gamma) or Syp. Consistent with this result, a PI-3 kinase inhibitor, wortmannin inhibited activation of JNK by PDGF. Furthermore, overexpression of P110 the catalytic domain of PI-3 kinase was sufficient for activation of JNKs which could be efficiently inhibited by dominant negative forms of Pas, Pac but not of RhoA or Cdc42. Taken together all of these findings suggest that activation of JNK by PDGF involves receptor association with PI-3 kinase activity, which in turn acts on a ras- and rac-dependent pathway. (C) 1997 Academic Press.
引用
收藏
页码:273 / 277
页数:5
相关论文
共 50 条
[31]   Activation of STAT3 by Gαs distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase [J].
Liu, Andrew M. F. ;
Lo, Rico K. H. ;
Wong, Cecilia S. S. ;
Morris, Christina ;
Wise, Helen ;
Wong, Yung H. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (47) :35812-35825
[32]   PHOSPHATIDYLINOSITOL-3 KINASE ACTIVATION-INDUCED UPON FC-GAMMA-RIIIA-LIGAND INTERACTION [J].
KANAKARAJ, P ;
DUCKWORTH, B ;
AZZONI, L ;
KAMOUN, M ;
CANTLEY, LC ;
PERUSSIA, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :551-558
[33]   Phosphatidylinositol-3 kinase (PI3-kinase) involvement in osteoclast attachment and spreading on bone [J].
Lakkakorpi, PT ;
Wesolowski, G ;
Zimolo, Z ;
Rodan, GA ;
Rodan, SB .
JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 :M423-M423
[34]   Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma [J].
Aziz, Saadia A. ;
Jilaveanu, Lucia B. ;
Zito, Christopher ;
Camp, Robert L. ;
Rimm, David L. ;
Conrad, Patricia ;
Kluger, Harriet M. .
CLINICAL CANCER RESEARCH, 2010, 16 (24) :6029-6039
[35]   EFFECTS OF GROWTH-FACTORS ON PHOSPHATIDYLINOSITOL-3 KINASE IN ASTROGLIAL CELLS [J].
POMERANCE, M ;
GAVARET, JM ;
BRETON, M ;
PIERRE, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 40 (06) :737-746
[36]   The phosphatidylinositol-3 kinase pathway regulates bladder cancer cell invasion [J].
Wu, X ;
Obata, T ;
Khan, Q ;
Highshaw, RA ;
White, RD ;
Sweeney, C .
BJU INTERNATIONAL, 2004, 93 (01) :143-150
[37]   Hyperglycemia secondary to phosphatidylinositol-3 kinase (PI3K) inhibition [J].
Sriravindrarajah, Arunan ;
Hurwitz, Joshua ;
Lim, Elgene ;
Greenfield, Jerry R. .
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2024, 2024 (04)
[38]   ACTIVATION OF PHOSPHATIDYLINOSITOL-3 KINASE BY LIGATION OF THE INTERLEUKIN-7 RECEPTOR IS DEPENDENT ON PROTEIN-TYROSINE KINASE-ACTIVITY [J].
DADI, H ;
KE, S ;
ROIFMAN, CM .
BLOOD, 1994, 84 (05) :1579-1586
[39]   Identification of Cytokines regulated by phosphatidylinositol-3 kinase in ovarian cancer. [J].
Moscova, M ;
Marsh, DJ ;
Baxter, RC .
CLINICAL CANCER RESEARCH, 2005, 11 (24) :8977S-8977S
[40]   Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer [J].
Xing, Mingzhao .
THYROID, 2010, 20 (07) :697-706